New drug targets rare Cancer's genetic weakness
Disease control
Recruiting now
This study tests a new drug called REM-422 in people with advanced adenoid cystic carcinoma (ACC), a rare cancer of the glands. The drug works by breaking down a specific genetic message (MYB) that helps the cancer grow. The goal is to see if the drug is safe and can shrink tumor…
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:32 UTC